US20090030327A1 - Optical coupler for in vivo examination of biological tissue - Google Patents

Optical coupler for in vivo examination of biological tissue Download PDF

Info

Publication number
US20090030327A1
US20090030327A1 US12/082,344 US8234408A US2009030327A1 US 20090030327 A1 US20090030327 A1 US 20090030327A1 US 8234408 A US8234408 A US 8234408A US 2009030327 A1 US2009030327 A1 US 2009030327A1
Authority
US
United States
Prior art keywords
optical
tissue
radiation
light
biological tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/082,344
Inventor
Britton Chance
Original Assignee
Britton Chance
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/367,939 priority Critical patent/US5596987A/en
Priority to PCT/US1996/000235 priority patent/WO1996020638A1/en
Priority to US08/860,789 priority patent/US5987351A/en
Priority to US09/440,922 priority patent/US6526309B1/en
Priority to US10/373,665 priority patent/US20040054290A1/en
Priority to US11/437,766 priority patent/US20060241502A1/en
Application filed by Britton Chance filed Critical Britton Chance
Priority to US12/082,344 priority patent/US20090030327A1/en
Publication of US20090030327A1 publication Critical patent/US20090030327A1/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6814Head
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/0033Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
    • A61B5/004Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/0059Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/0059Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0091Detecting, measuring or recording for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for mammography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14552Details of sensors specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14553Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/43Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4312Breast evaluation or disorder diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • A61B5/6853Catheters with a balloon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0233Special features of optical sensors or probes classified in A61B5/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04Arrangements of multiple sensors of the same type
    • A61B2562/046Arrangements of multiple sensors of the same type in a matrix array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/14Coupling media or elements to improve sensor contact with skin or tissue
    • A61B2562/146Coupling media or elements to improve sensor contact with skin or tissue for optical coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/0033Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
    • A61B5/0035Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Abstract

A spectrophotometric system for examination of biological tissue of interest includes a light source, a light coupling system, a light detector, and a processor. The light source is constructed and arranged to emit a light beam of visible or infra-red radiation. The light coupling system includes at least one mirror and is constructed and arranged to receive the emitted light beam and scan the light beam for introduction into the biological tissue of interest. The light detector is optically coupled to detect photons of radiation that have migrated over optical paths in the biological tissue of interest. The processor is operatively coupled to the light source and detector and is adapted to determine an optical property of the biological tissue of interest based on the changes between the introduced and detected radiation.

Description

    BACKGROUND OF THE INVENTION
  • Continuous wave (CW) spectrophotometers have been widely used to determine in vivo concentration of an optically absorbing pigment (e.g., hemoglobin, oxyhemoglobin) in biological tissue. The CW spectrophotometers, for example, in pulse oximetry introduce light into a finger or the ear lobe to measure the light attenuation and then evaluate the concentration based on the Beer Lambert equation or modified Beer Lambert absorbance equation. The Beer Lambert equation (1) describes the relationship between the concentration of an absorbent constituent (C), the extinction coefficient (ε), the photon migration pathlength <L>, and the attenuated light intensity (I/Io).
  • log [ I / I 0 ] L = ε i c i ( 1 )
  • However, direct application of the Beer Lambert equation poses several problems. Since the tissue structure and physiology vary significantly, the optical pathlength of migrating photons also varies significantly and can not be simply determined from geometrical position of a source and detector. In addition, the photon migration pathlength itself is a function of the relative concentration of absorbing constituents. As a result, the pathlength through an organ with high blood hemoglobin concentration, for example, will be different from the same with a low blood hemoglobin concentration. Furthermore, the pathlength is frequently dependent upon the wavelength of the light since the absorption coefficient of many tissue constituents is wavelength dependent. One solution to this problem is to determine ε, C, and <L> at the same time, but this is not possible with the pulse oximeters known previously.
  • Furthermore, for quantitative measurement of tissue of a small volume (e.g., a finger) photon escape introduces a significant error since the photons escaped from the tissue are counted as absorbed. Other errors may occur due to irregular coupling of light to the examined tissue or varying relative geometry of the input and detection ports.
  • The time resolved (TRS-pulse) and phase modulation (PMS) spectrophotometers can measure the average pathlength of migrating photons directly, but the proper quantitation of the time resolved or frequency resolved spectra can be performed only when the spectra are collected at a relatively large source-detector separation. This separation is difficult to achieve for a small volume of tissue such as the earlobe, a finger or a biopsy tissue.
  • Therefore, there is a need for a optical coupler used with a spectrophotometric system and method that quantitatively examines a relatively small volume of biological tissue.
  • SUMMARY OF THE INVENTION
  • The invention features a spectrophotometric system for examination of a relatively small volume of biological tissue of interest using visible or infra-red radiation.
  • According to one aspect of the invention, a spectrophotometric system for examination of a relatively small object of interest (e.g., biological tissue, organic or inorganic substance in a solid, liquid or gaseous state) using visible or infra-red radiation introduced to a path passing through the object. The system includes a spectrophotometer with an optical input port adapted to introduce radiation into the object and an optical detection port adapted to detect radiation that has migrated through a path in the object, photon escape preventing means arranged around the relatively small object of interest and adapted to limit escape of the introduced photons outside the object, and processing means adapted to determine an optical property of the object based on the changes between the introduced and the detected radiation.
  • According to another aspect of the invention, a system for examination of a relatively small volume of biological tissue of interest using visible or infra-red radiation includes a spectrophotometer with a light source adapted to introduce radiation at an optical input port, a detector adapted to detect radiation that has migrated through a path from the input port to an optical detection port, and a processor adapted to evaluate changes between the introduced and the detected radiation. The system also includes an optical medium of a relatively large volume, forming photon preventing means, having selectable scattering and absorptive properties, positioning means adapted to locate the biological tissue of interest into the migration path to create a tissue-medium optical path, the optical medium substantially limiting escape of photons from the tissue-medium optical path, and processing means adapted to determine a physiological property of the tissue based on the detected optical property of the tissue-medium optical path and the scattering or absorptive properties of the optical medium.
  • Preferred embodiments of these aspects of the invention include one or more of the following features.
  • The photon escape preventing means include an optical medium of a selectable optical property surrounding the object. The selectable optical property is an absorption or scattering coefficient.
  • The photon escape preventing means include an optical medium surrounding the object; the medium has at least one optical property substantially matched to the optical property of the object.
  • The spectrophotometer is a continuous wave spectrophotometer (CWS) as described in PCT applications WO 92/20273 and PCT/US95/15666, a phase modulation spectroscopic unit (PMS) as described in U.S. Pat. Nos. 4,972,331, 5,187,672, or a PCT application WO 94/21173, time resolved spectroscopic (TRS) unit as described in U.S. Pat. No. 5,119,815 or 5,386,827 or a PCT application WO 94/22361, or a phased array system as described in WO 93/25145, all of which are incorporated by reference as if set forth in their entireties herein.
  • The determined physiological property is the hemoglobin saturation, the concentration of an enzyme or the concentration of a tissue substance such as glucose.
  • The system performs a single measurement or a continuous, time-dependent monitoring of the selected physiological property.
  • The above-described system operates by introducing into the object, surrounded by the photon escape preventing means, electromagnetic radiation of a selected wavelength and detecting radiation that has migrated in the object from the input port to the optical detection port. The system determines an optical property of the object based on the changes between the introduced and the detected radiation. In addition, different photon escape preventing means having a surrounding optical medium with the optical property comparable to the optical property of the object may be selected. Then, the system measures again the optical property of the object. The measurements may be repeated iteratively until the optical property of the surrounding medium is substantially matched to the optical property of the object.
  • According to another important aspect, the invention is an optical coupling system for non-invasively monitoring a region of living tissue. The coupling system includes an excitation (input) port positionable at the tissue and adapted to introduce optical radiation into the monitored tissue, a first light guide defining an excitation channel for conveying the radiation from a source to the excitation port, and a detection port, positionable at the tissue, adapted to receive radiation that has migrated in the monitored tissue from the excitation port to the detection port. The detection port has a detection area larger than a input area of the excitation port. Connected to the detection port is a detecting light guide, for conveying the radiation from the detection port to an optical detector. The coupling system also includes optical matching fluid contained within a flexible optically transparent bag and disposed partially around the monitored tissue and the excitation and detection ports.
  • Preferred embodiments of this aspect of the invention includes one or more of the following features.
  • The optical coupling system may include multiple excitation (input) ports positionable at the tissue and adapted to introduce radiation of the source into the monitored tissue, and multiple light guides, each defining an excitation channel for conveying the radiation from the source to the corresponding excitation port.
  • The optical coupling system may also include multiple detection ports positionable at the tissue and adapted to receive radiation that has migrated in the monitored tissue, and multiple detecting light guides each connected to the corresponding detection port for conveying the radiation from the detection port to at least one optical detector.
  • The optical matching fluid may be positioned partially between the ports and the monitored tissue. The optical matching fluid may have known scattering or absorptive properties.
  • The optical coupling system may further include means for changing scattering or absorptive properties of the optical matching fluid and means for calibrating the coupling system by controllably changing scattering or absorptive properties of the optical matching fluid.
  • According to another important aspect, the invention is an optical coupler for in vivo examination of biological tissue. The optical coupler includes an optical input port of a selected input area positionable on or near the examined tissue, a first light guide optically coupled to the optical input port and constructed to transmit optical radiation of a visible or infra-red wavelength from a source to the optical input port, wherein the optical input port is constructed and arranged to introduce the optical radiation to the examined tissue, and an optical detection port of a selected detection area positionable on or near the examined tissue. The detection port is constructed and arranged to receive radiation that has migrated in the examined tissue from the input port to the detection port. Optically coupled to the detection port is a detector light guide constructed to transmit the radiation from the detection port to an optical detector. The optical coupler also includes optical medium disposed at least partially around the examined tissue and the input and detection ports and constructed to limit escape of, or account for photons escaped from the examined tissue.
  • According to another important aspect, the invention is an optical coupler for in vivo examination of biological tissue. The optical coupler includes an optical input port of a selected input area directed toward the examined tissue, an optical detection port of a selected detection area directed toward the examined tissue, and optical medium disposed at least partially around the examined tissue and the input and detection ports. The optical medium is also placed between the tissue and the input area of the input port and between the tissue and the detection area of the detection port, and the optical medium exhibits known scattering or absorptive properties. Optically coupled to the optical input port is a first light guide constructed to transmit optical radiation of a visible or infra-red wavelength from a source to the optical input port that is constructed and arranged to introduce the radiation to the optical medium. The optical detection port is constructed and arranged to receive radiation that has migrated in the examined tissue and the optical medium from the input port to the detection port. Optically coupled to the detection port is a detector light guide constructed to transmit the radiation from the detection port to an optical detector.
  • According to another important aspect, the invention is an optical coupling system for non-invasively monitoring a region of biological tissue. The coupling system includes a source probe made of at least two optical fibers having distal ends positionable directly at the tissue. Each distal end forms an input port constructed to introduce optical radiation into the examined tissue. The fibers have proximal ends constructed and arranged to form at least one coupling port for receiving the radiation from a source. The coupling system also includes a detection probe made of at least one optical fiber having a distal end positionable directly at the tissue. The distal end forms a detection port constructed to receive radiation that has migrated in the examined tissue. The fiber has a proximal end constructed and arranged to form at least one coupling port for conveying the detected radiation to an optical detector.
  • The optical fibers may include at the input port or at the detection port an optical matching medium arranged to achieve a desired coupling of the radiation.
  • Preferred embodiments of this aspect of the invention includes one or more of the following features.
  • The optical medium may have absorptive or scattering properties substantially matched to the absorptive or scattering properties of the examined tissue.
  • The optical coupler may further include an optical system constructed and arranged to alter controllably absorptive or scattering properties of the optical medium. The system may be adapted to substantially match the absorptive or scattering properties of the optical medium to the absorptive or scattering properties of the examined tissue.
  • The optical coupler may further include a second input port of a selected input area, and a light guide optically coupled to the second input port. The detection port may be placed symmetrically relative to the first input port and the second input port. The detection port may be arranged in a transmission geometry or in a backscattering geometry relative to the input ports.
  • The optical coupler may accommodate movable optical ports relative to the examined tissue.
  • The optical coupler may further include multiple input ports, and multiple light guides optically coupled to the corresponding input ports. The multiple input ports may be arranged to introduce simultaneously radiation of known time varying pattern to form resulting introduced radiation possessing a substantial gradient of photon density in at least one direction. The multiple input ports may form a one dimensional or two dimensional array. The optical detection port may be movable to another location relative to the examined tissue.
  • The optical coupler may also include multiple detection ports, and multiple detector light guides optically coupled to the corresponding detection ports.
  • The optical medium may be made of a solid, liquid, or gas. The optical medium may also include solid particles of smooth, spherical surface, or styrofoam. The optical medium may also include a liquid of selectable scattering or absorptive properties such as an intralipid solution. The optical medium may include a pliable solid of selectable scattering or absorptive properties.
  • The optical coupler may have the detection area of the optical detection port is larger than the input area of said optical input port.
  • The optical coupler may further include a port for the needle localization procedure or may be arranged for ultrasonic examination of the tissue performed simultaneously with, or subsequently to the optical examination of the tissue. The optical coupler may further include a set of MRI coils arranged to perform an MRI examination of the tissue.
  • The optical coupler may be disposed on an endoscope, catheter, guidewire or the like for insertion via a body passage, or transcutaneously, to internal tissue. The optical coupler is designed for visual and spectroscopic examination the selected internal tissue. The catheter may include an inflatable balloon that can press the input and detection ports against the tissue selected for spectroscopic examination. The catheter may also include a biopsy attachment for taking a biopsy specimen from a tissue region before or after the spectroscopic examination.
  • According to another important aspect, the invention is an optical coupler for in vivo examination of biological tissue. The optical coupler includes an optical input port of a first selected area directed toward the examined tissue and a second selected area oppositely oriented to the first area, and an optical detection port of a selected detection area directed toward the examined tissue. The input port is constructed to accept a light beam scanned over the second area and introduce the beam to the tissue at the first area. The optical coupler also includes optical medium disposed at least partially around the examined tissue and the input and detection ports. The optical medium is also placed between the tissue and the input area of the input port and between the tissue and the detection area of the detection port. The optical medium exhibits known scattering or absorptive properties. The optical detection port is constructed and arranged to receive radiation that has migrated in the examined tissue and the optical medium from the input port to the detection port. Optically coupled to the detection port is a detector light guide constructed to transmit the radiation from the detection port to an optical detector.
  • Preferred embodiments of this aspect of the invention includes one or more of the following features.
  • The detection area of the optical detection port may include a multiplicity of detection subareas located at a known position of the detection area. Each detection subarea is constructed and arranged to receive radiation that has migrated in the examined tissue and convey the received radiation to a detector.
  • The optical detector may include an array of semiconducting detectors each receiving light from a corresponding detection subarea via the detector light guide. Thus a time profile of the detected radiation can be measured at the individual locations.
  • The light beam may be scanned over the input port using a selected pattern relative to a detection sequence accumulated over the detection subareas. Then, by knowing the input and detection locations of the migrating photons, average photon migration paths may be calculated.
  • In general, the optical coupling system provides an excellent coupling of light to the examined tissue. The coupling system may also substantially prevent escape of photons from the tissue surface and achieve semi-infinite boundary conditions for the introduced radiation. A larger volume of optical medium is usually used for a small tissue size. The optical coupling system also achieves precisely a selected geometry of the input (excitation) ports and the detection ports regardless of the tissue shape or property. The precise geometry is frequently important for proper evaluation of the photon migration patterns measured by the continuous wave (CWS) unit, the phase modulation unit, the TRS unit, or the phased array unit.
  • BRIEF DESCRIPTION OF THE DRAWING
  • FIG. 1 is a diagrammatic view of a spectrophotometric system for examination of tissue of a relatively small dimension.
  • FIGS. 2 and 2A show different views of a cylinder for preventing escape of photons during spectrophotometric measurements of a finger.
  • FIG. 2B shows a set of cylinders of preselected optical properties for a finger oximetry.
  • FIG. 3 is a diagrammatic view of an optical fiber holder for a spectrophotometric study of the head.
  • FIG. 4 a plan view of an optical coupling system for monitoring the oxygenation-deoxygenation state of the hemoglobin within the brain tissue of a subject.
  • FIG. 4A depicts an optical coupling system for examination of the brain tissue utilizing several input and detection ports.
  • FIGS. 5 through 5C depict several optical coupling systems for optical examination of the breast tissue.
  • FIG. 5D depicts an optical coupling system with a two dimensional input array also adapted for the needle localization procedure.
  • FIGS. 5E and 5F depict optical coupling systems adapted for optical examination together with ultrasound and magnetic resonance imaging, respectively.
  • FIG. 6 depicts an optical coupling system with optical windows adapted for a scanning system with an array detector.
  • FIGS. 7 and 7A depict a “hairbrush” optical coupling system for optical examination of the brain.
  • FIGS. 8 and 8A depict a “hairbrush” optical coupling system for optical and MRI examination.
  • FIGS. 9 and 9A depict a scanning coupling system constructed for examination of breast tissue.
  • FIGS. 10, 10A and 10B depict an optical coupler disposed on a catheter.
  • FIGS. 11 and 11A depict a spectrophotometer disposed on a catheter.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Referring to FIG. 1, the basic principle of operation of different optical couplers is explained by describing a system 10. System 10, designed for examination of biological tissue of a relatively small volume, includes an optical medium 12 of selectable optical properties, a spectrophotometer 18, a titrimetric circulation system 30, and computer control 35. Biological tissue of interest 14, attached to a locator 15, is immersed in optical medium 12. Spectrophotometer 18 examines optical properties of medium 12 by employing visible or infra-red light conducted via light guides 20 and 22. Light guides 20 and 22, which in a preferred embodiment are optical fibers, are connected to a light source 21 and a light detector 23, respectively. Photons introduced at an optical input port 19 migrate in medium 12 through a scattering and absorptive path and are detected at a detection port 21. The selectable fixed geometry of input port 19 and detection port 21 controls the migration path, i.e., optical field 25.
  • System 30 is adapted to change precisely the scattering and absorptive properties of medium 12. Medium 12 includes intralipid solution (made by Kabi Vitrum, Inc., Clapton, N.C.) that exhibits scattering properties depending on its concentration and carbon black india ink that exhibits absorptive properties. The scattering or absorptive properties of medium 12 can be either maintained constant and uniform by properly mixing the solution or can be changed almost continuously by changing the concentration of the constituents in titration system 30. Tubes 32 and 34 are adapted for continuous circulation of the solution.
  • In system operation, tissue 14 is first located away from optical field 25. Spectrophotometer 18 examines medium 12 in field region 25, and control 35 compares the detected data to the preselected values of the absorption coefficient (μa) and the scattering coefficient (μs). Next, locator 15 positions tissue 14 into field 25 and spectrophotometer 18 measures the optical properties of tissue 14 and medium 12. From the spectral data collected with and without tissue 14, computer control 35 determines the optical properties of tissue 14.
  • In another preferred method of operation, after measuring the optical properties of medium 12, the scattering and absorptive properties of medium 12 are matched by titration to the properties of tissue 14 so that, when inserted into field 25, tissue 14 does not cause perturbation of field 25. After matching the scattering and absorption coefficients of medium 12 to the coefficients of tissue 14, spectrophotometer 18 detects the same data with or without tissue 14. The known titrated values of μa* and μs* are equal to the μa and μs values of tissue 14. The matching process is performed by first matching μa and then μs or vice versa.
  • The described method is applicable to both in vivo and in vitro tissue examination. Tissue 14 may be a biopsy specimen enclosed in an optically transparent material or a portion of a human finger inserted into medium 12. The wavelength of light used by spectrophotometer 18 is selected depending on the tissue component of interest (e.g., hemoglobin, oxyhemoglobin, glucose, enzymes); it is within the scope of this invention to use multiple wavelengths.
  • The present invention envisions the use of different preferred embodiments of optical medium 12. Referring to FIG. 2, a hollow cylinder 42 filled with medium 12 surrounds, for example, a finger 40 and prevents escape of introduced photons. The optical properties, pressure and volume of medium 12 are controlled by system 30 connected to cylinder 42 by tubes 32 and 34. The inside walls of cylinder 42 are made of a pliable, optically transparent barrier 44. After insertion into cylinder 42, barrier 44 fits snugly around the finger. The dimension of inside barrier 44 is such that after finger 40 is withdrawn, medium 12 fills the volume of cylinder 42 completely. This enables both a background measurement of medium 12 and a measurement of finger 40 in medium 12 in the same way as described in connection with FIG. 1. Optical field 25, controlled by the position of input port 19 and detection port 21, is either in transmission or reflection geometry.
  • Referring to FIG. 2B, in another embodiment, cylinder 42 is replaced by a set of cylinders 42A, 42B, 42C . . . , each containing medium 12 in a fluid or solid state with a constant preselected absorption and scattering coefficient. The solid optical medium is titanium oxide, or other scatterer, imbedded in an absorbing, pliable medium such as a gel.
  • A human finger is inserted into the individual cylinders, and the optical properties of the inserted finger are measured by spectrophotometer 18. Using the known optical properties of the cylinders and the input port-detection port geometry, the optical properties (i.e., μa and μs) of the finger can be matched to the properties of one of the cylinders.
  • The preferred embodiments of spectrophotometer 18 are a continuous wave spectrometer, a phase modulation spectrometer and a time-resolved spectrometer, all of them described in the above-cited documents.
  • System 10 operating with a dual wavelength continuous wave spectrometer is used, for example, as a finger oximeter. As shown in FIG. 2A, the vast majority of photons introduced into finger 40 are prevented to escape by surrounding medium 12. Thus, the introduced photons are either absorbed or reach detection port 21 and are registered by the detector. No error of counting the escaped photons as absorbed occurs. The background spectral data corresponding to each selected value of μa* and μs* of cylinder 42 are stored in the system that can match the values of μa and μs of the finger and the cylinder for each wavelength. For the continuous wave spectrometer that operates at two wavelengths sensitive to hemoglobin (Hb) and oxyhemoglobin (Hb02) (e.g., 754 nm and 816 nm), the hemoglobin saturation (Y) is calculated by taking the ratio of absorption coefficients and using the following equation for the oxygen saturation:
  • Y ( X 100 % ) = 38 - 18 μ a 754 μ a 816 25 + 3 μ a 754 μ a 816 ( 2 )
  • wherein the coefficients are determined from the extinction values of hemoglobin at 754 nm and 816 nm that are εHb=0.38 cm−1 mM−1, εHb=0.18 cm−1 mM−1,
    respectively, and the difference extinction coefficients between oxyhemoglobin and hemoglobin that are ΔεHb0-Hb=0.025 cm−1 mM−1 and ΔεHb0-Hb=0.03 cm−1 μmM−1, respectively.
  • As known to a person skilled in the art, in the hemoglobin saturation measurement the oximeter normalizes the detected data to eliminate fluctuations due to the changing blood volume. However, the volume changes can be used to detect the pulse rate.
  • Alternatively, a phase modulation spectrometer is used to measure the photon migration by detecting the intensity and the phase shift θ of sinusoidally modulated light introduced at a distance of several centimeters from the detector. For tissue of a small volume, the optimal distance between the input port and the irradiation port is achieved using optical medium 12. Furthermore, medium 12 substantially eliminates the photon escape.
  • The detected phase shift is directly related to the mean of the distribution of photon pathlengths shown in FIG. 2A. Photon migration theory predicts that the detected photons can be represented by a three dimensional “banana-shaped” distribution pattern in the reflection geometry or a “cigar-shaped” distribution pattern in the transmission geometry. Inserting tissue 14 into the center of field 25 causes nonuniformities in the distribution of pathlengths, i.e., the banana-shaped optical field 25 is nonuniform, if the tissue absorption properties are different from the properties of medium 12. If μa of the tissue is smaller then that of the surrounding medium, the average pathlength <L> decreases since photons with longer pathlengths are more absorbed and vice versa. Thus, tissue 14 causes changes in the pathlength and the phase shift, θ.
  • Furthermore, the detected intensity provides a modulation index (M) that is an important measure of the absorption and scattering properties of a strongly scattering medium. The modulation index is determined as the ratio of the AC amplitude (Aλ) to the sum of the AC and DC (DCλ) amplitude.
  • M λ 1 = A λ 1 A λ 1 + D C λ 1 ( 3 )
  • As described in Sevick et al. in Analytical Biochemistry Vol. 195, pp. 330-351, 1991, incorporated by reference as if set forth herein, for low modulation frequencies (i.e., 2πf<<μac) the phase shift is a direct measure of the mean time of flight, <t>, i.e., θ→2πf<t>. In a medium wherein all photons travel at a constant speed, c, the phase shift describes the effective, mean pathlength θ→2πf<L>/c. Here, all pathlengths are weighted equally. The determined pathlength is used in Beer-Lambert equation for determination of the absorption properties.
  • As the modulation frequency increases, the shorter pathlengths become more heavily weighted. At frequencies (i.e. 2πf >>μac), the phase shift is no longer a good measure of the distribution of pathlengths and is directly proportional to the absorption coefficient, μa, and the effective scattering coefficient, (1−g)·μs
  • θ λ = a ρ ( 1 - g ) μ s f { 1 - μ a C 4 π f } ( 4 )
  • Since the effective scattering coefficient is wavelength independent, ratio of the phase shifts measured at two wavelengths can be written
  • θ λ 1 - θ 0 λ 1 θ λ 2 - θ 0 λ 2 = μ a λ 1 μ a λ 2 ( 5 )
  • wherein θo λ is the phase shift at the measured wavelength arising from the scattering and background absorption. The ratio of the absorption coefficients is used, for example, for determination of the tissue saturation, Y. A dual frequency, dual wavelength phase modulation spectrometer can be used to determine the saturation by eliminating θo. The ratio of absorption coefficients is expressed as a function of the phase shifts measured at different frequencies and wavelengths.
  • ( θ f 1 λ 1 / f 1 ) - ( θ f 2 λ 1 / f 2 ) ( θ f 1 λ 2 / f 1 ) - ( θ f 2 λ 2 / f 2 ) = μ s λ 1 μ s λ 2 ( 6 )
  • Alternatively, a time-resolved spectrometer (TRS-pulse) is employed which introduces, at input port 19, pulses of light on the order of less than a picosecond. Photons traveling through a distribution of migration pathlengths 25 are collected at the detection port 21. The intensity of detected light in the reflectance geometry, R(ρ,t), (or the transmittance geometry T(ρ,d,t)) was determined by solving the diffusion equation in an infinite media as a Green's function with near infinite boundary conditions. Due to the semi-infinite media condition in the reflectance geometry, the separation of the input and output ports must be on the order of several centimeters to use the following equation.
  • t log eR ( ρ , t ) = - 5 2 t - μ a C + ρ 2 4 DCt ( 7 )
  • For t→∞ the absorption coefficient μa is determined as
  • lim t = t log e R ( ρ , t ) = - μ a c ( 8 )
  • wherein ρ is the separation between input and detection ports and c is speed of light in the medium. The effective scattering coefficient (1−g) μs is determined as
  • ( 1 - g ) μ s = 1 ρ 2 ( 4 μ a c 2 t max 2 + 10 ct max ) - μ a ( 9 )
  • wherein tmax is the delay time at which the detected reflectance time profile (R(ρ,t)=I(t)) reaches maximum. The right hand side of Eq. 7 is the decay slope of the arrival time of the modified pulses. The absorption coefficient is quantified by evaluating the decaying slope of the detected pulse, as described in Eq. 7. The effective scattering coefficient, (1−g)·μs, is determined from Eq. 9. For the known μa and μs and the input port, output port geometry, the system has a unique time profile I(t). The stored profile is compared to the time profile detected for the introduced tissue to obtain a difference profile that possesses the scattering and absorption coefficients of tissue 14. Alternatively, μa and μs of medium 12 and tissue 14 are matched by varying the scattering and absorptive properties of medium 12 so that the detected time profile is not altered by introducing tissue 14.
  • The TRS system can be used to calibrate a CW oximeter to quantify the measured data. To account for the difference between the geometric distance (ρ) of the input port and the detection port and the pathlength (<L>), some oximeters use a modified Beer-Lambert equation with a differential pathlength factor (DPF) as follows:

  • absorbance=DPF·ε·[C]  (10)
  • However, the differential pathlength factor can not be precisely determined by the CW oximeters since it depends on the pathlength. The TRS determines DPF using the absorption (μa) and scattering (μs) coefficients as follows:
  • DPF = 3 2 ( 1 - g ) μ s μ a ( 11 )
  • Alternatively, a phased array spectrometer, described in WO 93/25145, is employed to localize a tissue anomaly or image a selected tissue region.
  • The described systems are constructed to perform either a single measurement or a continuous, time-dependent monitoring of the selected physiological property. The may include a visual display for continuous monitoring of the measured values and may include a alarm that issues a warning signal when the measured value equals to a preselected value.
  • An alternative embodiment of the optical coupler is an optrode holder 45 shown in FIG. 3. Optrode holder 45 is used for examination of the head of a neonate (46). Optical fibers 20 and 22 are projected into a solid scattering material 47, i.e., an escape preventing optical medium, such as styrofoam, which affords a return pathway for escaping photons 48. The pathlength of the migrating photons in the tissue is much longer since the photons return to the tissue by the scattering materials, as shown by the zig-zag arrows 48. Thus, the banana-shaped pattern will penetrate more deeply and meaningful spectroscopic data can be obtained at smaller input-output fiber separations without the danger of photon leakage or “short” by substantially direct pathways. Alternatively, the styrofoam may be replaced by a metallic foil that reflects back to the tissue radiation of visible or near infrared wavelengths. The foil surrounds the input and detection ports and the examined tissue.
  • Referring to FIG. 4, another embodiment is an optical coupling system that comprises an optical coupling device 114 and a spacer-coupler 116 for coupling the forward end of optical coupling device 114 to the back of the head 110 to monitor a tissue region of the brain. (A similar system can monitor other tissue regions, such as internal organs and muscles.) The spacer-coupler 116 is a thin, flexible, liquid-filled bag that is inflated by optical matching fluids to the condition depicted. The spacer-coupler 116 also serves as a cushion, providing a soft interface between the forward end of the coupling device 114 and the head 110.
  • The optical coupling device 114 comprises a light guide 120 in the form of a bundle of optical fibers constituting an excitation channel for supplying near red radiation (NR) from the rear of the coupling device to head 110. The distal end 121 of the light guide 120 adjacent the head 110 forms an excitation port. A detecting light guide 124, which is also comprised of optical fibers, extends along the length of the coupling device. Surrounding a distal end 125 of detecting light guide 124 is an opaque specular barrier 122. The barrier blocks substantially all direct and reflected radiation except that migrating from a region spaced from the tissue surface; i.e., barrier 122 acts as an absorber of the near-surface rays. This enables the connected spectrophotometer to determine, for example, the oxygenation state of hemoglobin deep within the tissue rather than at the surface. To block the leakage of the radiation from the length of the excitation light guide into the detecting light guide, a thin coating 130 of material substantially opaque to the radiation is preferably placed around each of the fiber optic bundles 120, 124.
  • The monitoring systems of FIG. 4 can be calibrated by the flowing of a mixture of yeast cells and blood of known oxygenation properties through the spacer-coupler 116 to determine the ab initio sensitivity of the system to oxy-deoxy-hemoglobin solutions of blood. The accuracy of the monitoring system can be improved by compensating for changes of the albedo of the hair and skin of the subject and also for changes in the thickness of the spacer-coupler 116. Such compensation can be achieved by providing an annulus of optical fibers closely surrounding the excitation light guide 120, but separated therefrom by an opaque coating. The excitation radiation supplied through the light guide 120 and detected by the annulus of fibers at the forward end of the coupling device can be used to monitor the backscattered radiation and also regulate the lamp intensity so as to maintain constant incident radiation.
  • A similar coupling system is shown in FIG. 4A. The coupling system includes a spacer-coupler 116 and two sets of excitation ports 121A, 121B, 121C, and detection ports 125A and 125B, each arranged in a row, and a central row of detection ports 126A, 126B and 126C. The input area of the excitation ports has a diameter of 100 μm to 1 mm and the detection area of the detection ports has a diameter of 1 mm to 10 mm. The larger detection area is used to increase the collection of the migrating photons. As described above, tubes 32 and 34 are connected to a titration system and used for circulation and controlled optical changes of the optical matching fluid contained within a pliable, optically transparent barrier. As described above, the scattering or absorption properties (μa, μs′) of the optical medium may be selected to match μa of the tissue, μs′ of the tissue or both. In several applications, it is advantageous to match μs′ and keep μa very low to substantially eliminate absorption in the optical medium. Thus the absorption coefficient will mainly depend on the properties of the examined tissue.
  • Each row of the excitation ports and the detection ports may be used for independent examination of the brain tissue by performing a p-scan as described in a PCT/US95/15666, incorporated by reference as if set forth herein. Light guides deliver radiation to individual excitation ports 121A, 121B, 121C in sequence and the introduced photons migrate through the patient's brain to detection ports 125A, 125B over the corresponding, “banana-shaped” migration paths that depend on the excitation port-detection port separation. Based on the detected, normalized intensities, the spectrophotometer calculates the values of μa and μs′ that are used to detect a brain bleed, a cerebral hypoxia or tissue plaque characteristic of Alzheimer's disease.
  • The central row of detection ports 126A, 126B and 126C is used for a separate phased array measurement described is a PCT/US95/15694, incorporated by reference as if set forth herein. Light from two sources is introduced into the examined brain tissue at excitation ports 121 and 121A′, sequentially. The intensities of the two sources are selected so that a detection port 126A is located on a null plane of equal intensity in the tissue. A detector detects sequentially radiation that has migrated from the input ports 121A and 121A′ to detection port 126A. The detected signals are stored in a sample-and-hold circuit and subtracted in a subtraction circuit to create a differential signal. The differential signal is then used to examine the tissue. This cancellation measurement is performed over the three sets of excitation and detection ports (i.e., 121A, 121A′, and 126A; 121B, 121B′, and 126B; 121C, 121C′, and 126C, respectively) to examine the frontal lobe of the brain.
  • Referring to FIG. 5, similar type of the optical coupling system is used to examine breast tissue 11. A cylindrical optical coupler includes a hollow cylinder 42 filled with optical medium 12. Cylinder 42 is placed over the breast 11 near the chest wall 11A. As described above, the optical properties, pressure and volume of medium 12 are controlled by system 30 connected to cylinder 42 by tubes 32 and 34. The optical matching fluid is contained within pliable, optically transparent barrier 44. The inside walls of cylinder 42 may be coated with a film that reflects light in the visible or near infra-red range back to the matching fluid. The optical coupler uses cylinders 42 of different sizes or a cylinder with an adjustable volume so that the coupler can have a selected distance between the breast surface and the inside wall of cylinder 42. The preferred distance is about 1 centimeter, but for a very small tissue a larger distance is preferable to achieve semi-infinite boundary conditions. Thus the coupler is also useful for examination of the breast of a small size or after a surgical removal of the breast tissue. After placement of cylinder 42, the volume of medium 12 is adjusted so that barrier 44 fits snugly around the examined breast. Alternatively, the optical medium is a pliable solid, for example, an absorbing gel containing metallic or oxide spherical particles, or silky glass beads as scatterers. When the cylinder is placed firmly on the examined breast, the excess optical medium contained within the pliable barrier is pushed outside of the cylinder.
  • As described above, spectrophotometer 18 measures the optical properties of tissue 11 and medium 12. Light guides 20 and 20A are connected to light source 21, and light guide 22 is connected to light detector 23. Photons introduced at an optical input ports 19 and 19A migrate in medium 12 over scattering and absorptive paths and are detected at detection port 21. The optical medium achieves a uniform coupling of light to the tissue that is usually pliable and enables preselected fixed geometry of the input end detection ports. Spectrophotometer 18, which is a continuous wave spectrophotometer, a phase modulation spectrophotometer or time resolved spectrophotometer, evaluates the breast tissue similarly as described above for the biopsy specimen or the finger.
  • Furthermore, the optical resolution may be increased when spectrophotometer 18 together with the optical coupler are calibrated on a “normal” tissue region and then used to examine another tissue region that when “normal” should have the same optical properties as the first tissue region. For example, the optical coupler is first placed on the left breast and the optical properties of the tissue are measured. Then, the optical coupler is placed on the right breast suspected to have an abnormal tissue region. The optical properties of the right breast are measured and evaluated relative to the optical properties of the normal tissue of the left breast. The relative measurement can be performed by measuring the two sets of data independently and subtracting or comparing them to them to each other. Alternatively, two spectrophotometers, each with an optical coupler placed on one breast, are used simultaneously using a lateralization detector. Such technique is described in general (and specifically for examination the brain) in a PCT application WO 92/20273, filed May 18, 1992, incorporated by reference as if set forth herein.
  • Alternatively, spectrophotometer 18 is a phased array system described in the PCT/US95/15694 application cited above. FIG. 5A depicts an optical coupler for a measurement using a transmission geometry, and FIG. 5B depicts an optical coupler for a measurement using a reflection geometry that was already described for coupling system of FIG. 4A. FIG. 5C depicts an optical coupler for a phased array system that introduce simultaneously from input ports 19, 19A, 19B and 19C radiation of known time varying pattern that form resulting introduced radiation possessing a substantial gradient of photon density in at least one direction. The directional introduced radiation is perturbed by a tissue inhomogeneity (e.g., a tumor, bleeding) and is detected at the detection location 21. Cylinder 42 may include a slit opening to accommodate movement of fiber 22 so that detection port 21 may be located at several different positions. The tissue is examined or imaged by scanning the introduced directional field in two or three dimensions and moving the detection port over a predetermined geometry, as described in the WO 93/25145 document.
  • A similar optical coupler for a two dimensional phased array system is shown in FIG. 5D. A hollow box 42A filled with optical medium 12 contained within a pliable, optically transparent barrier 44 includes several optical input ports 19, 19A, 19B, 19C, . . . , arranged to form a two dimensional array, and a slit 49 constructed to receive detection port 21 of detection fiber 22 or an optical window. Alternatively, port 19 can be used as the detection port in a backscattering geometry. The coupler may also include a port 50 adapted for the needle localization procedure. (If another access is needed, port 19 may be constructed to accommodate both an optical fiber or the needle.) The inner walls of box 42A are lined with a reflecting material that returns photons back to fluid 44. When the coupler is used in the needle localization procedure, the tumor is first identified by X-ray pictures taken through box 42A. While the X-ray pictures are taken, optical fluid 44 may be withdrawn to avoid high attenuation of X-rays. Then, needle 51 is placed through port 50 to mark the tumor with a metal wire. The tumor is then examined or localized using the two dimensional phased array. Ports 19 or 50 may also be used for biopsy of the localized tumor.
  • Optical couplers used for ultrasound examination and magnetic resonance imaging in conjunction with the optical spectroscopy are depicted in FIGS. 5E and 5F, respectively. Referring to FIG. 5E, the optical coupler of FIG. 5 includes a port 52 constructed to accept an ultrasound probe. Referring to FIG. 5F, the optical coupler for magnetic resonance imaging is made of non-magnetic materials and includes a set of MRI coils 56 located around the tissue. The tissue is imaged by using both MRI and optical techniques, wherein the image resolution may be increased using contrast agents suitable for both MRI and optical examination, as described in the WO 94/22361 application, incorporated by reference as if set forth herein.
  • Referring to FIG. 6, in another embodiment, the optical coupler includes a set of optical windows instead of the input and detection fibers. The coupler includes a hollow cylinder 42A, filled with optical medium 12 contained within a pliable barrier, which has three optical windows 63, 64A and 64B. A light beam emitted from a light source 62 of a spectrophotometer 60, is directed to a selected location of input port 63 by a set of mirrors 68A and 68B and other optical elements. The optical system stores the exact position of the input beam relative to the examined tissue. After migration in tissue 11, the altered light is detected at detection ports 64A or 64B using a detector 65. Detector 65 includes, for example, an array of semiconducting detectors. Optical detection ports 64A or 64B are formed from an array of detection subareas, and each subarea conveys received radiation to the corresponding semiconducting detector. Thus, the system can record intensity and exact co-ordinates of the detected radiation. Based on the known input radiation and its co-ordinates and detected radiation for the individual detector locations, the system characterizes the tissue as described in the PCT application WO 93/25145.
  • Referring to FIG. 7, another embodiment of the optical coupling system is a hairbrush optical coupler 70. This optical coupler is designed to provide optimal coupling of light to and from brain tissue in regions where the skull is covered by hair. Coupler 70 includes at least one source probe 72 and at least one detection probe 75. Source probe 72 is made of approximately twenty optical fibers of 0.5 millimeter to 3 millimeter in diameter and at least one half centimeter in length. Input ports 73 (i.e., irradiation tips) of the fibers of source probe 72 are arranged to form a selected structure (e.g., a matrix, mosaic, circular or linear structure) depending on the desired input geometry and the type of the examined tissue. Each irradiation tip of the fiber may include an optical matching material (e.g., a plastic, a gel-like material, a coating or the like) located between the fiber and the tissue and designed to introduce light efficiently into the examined tissue. At the proximal end, probe 72 has one or more light coupling ports 74. The probe has a single light coupling port made of the fibers bundled together and arranged to achieve efficient coupling of light from a light source (e.g., a light bulb, a light emitting diode, a laser) to the probe. Alternatively, the probe has multiple light coupling ports (e.g., one port per fiber), wherein the generated light is coupled into the fibers sequentially or simultaneously.
  • Detection probe 75 includes one or more detection ports 76 and one or more light coupling ports 77. Detection probe 75 has a similar design as source probe 72, but may have a larger number of individual fibers in order to collect a sufficient amount of light that has migrated in the tissue. At the proximal end, the detection fibers may also be bundled together to form a single light coupling port 77, which provides good coupling to a wide area detector (e.g., a diode detector, a PMT detector or a MCPD detector). Since source probe 72 and detection probe 75 have a similar construction, they may be used interchangeably. Several source probes and detection probes may be coupled to an optical sequencer or multiplexer constructed to transmit and receive light in a desired manner. The probes are made of cladded fibers to eliminate crosstalk.
  • Source probe 72 and detection probe 75 are mounted on a support member constructed to achieve a selected position of the fibers and a desired separation of the input ports and the detection ports. The support member can also transmit pressure to the fiber tips for improved coupling of light to the tissue. A connected spectrophotometer (such as a TRS-pulse, PMS, CW, or phased array spectrophotometer) probes deep tissue at large separations of the ports (Q=5 cm to 10 cm) and probes a dermal layer at small separations (Q=0.5 cm to 2 cm).
  • The hairbrush optical coupler can be used for examination of symmetrical tissue regions of the brain, breast, arm, leg or other, as is described in the WO 92/20273 application. The hairbrush optical coupler can be also employed to detect asymmetrical tissue properties of optically symmetrical body regions. FIG. 7A depicts the hairbrush coupler attached to the head; specifically, to the parietal bones of a newborn which still has the characteristic opening called anterior fontanel. Input ports 73A and 73B of source probes 72A and 72B, respectively, are located on symmetrical locations of the corresponding parietal bones (or the temporal bones, the occipital bone, etc.). Detection ports 75A and 75B are spaced the same distance (Q, usually 3 cm to 8 cm) from the corresponding input ports 73A and 73B. The spectrophotometer introduces radiation of a selected wavelength at each input port and detects radiation at each detection port. The spectrophotometer stores the detected data separately and correlates them together or with a stored data corresponding to the individual brain regions to identify any asymmetry in tissue properties. Alternatively, the spectrophotometer measures a differential signal directly. Normal tissue provides a substantially symmetrical signal. A detected asymmetry may be caused by a tissue disease, such as localized bleeding, an asymmetric stroke volume, or another pathological condition. (For example, see S. P. Gopinath et al., J. Neurosurg., 79, 1993.)
  • In another embodiment, a multifiber hairbrush probe is used for imaging of the brain. For this purpose, a series of semirigid 1 mm fibers is embedded in a styrofoam or plastic helmet. When the helmet is attached to the head, the input ports of the fibers project through the hair to the surface of the scalp. The patient's head is covered by, for example, 4 rows of 8 fibers extending from the frontal region to the occipital region. A larger number of fibers is used when a higher resolution of the image is needed. Each fiber is coupled at its optical coupling port to an optical sequencer or multiplexer. This way any fiber may be coupled to a light source or a light detector of an optical imager described in PCT/US93/05868 or PCT/US95/15694.
  • Referring to FIG. 8, in another embodiment, the hairbrush optical coupler is constructed for in vivo examination of tissue using simultaneously magnetic resonance imaging (MRI) and medical optical imaging (MOI). The coupler includes a styrofoam cap 85 with four rows of 8 fibers extending from frontal to occipital region of the patient's head 88 located inside an MRI magnet 90. The optical fibers extend through the hair to the skull and include ferrite caps. Each fiber is coupled at its optical coupling port to a fiber junction box 92. Fiber junction box 92, located outside of magnet 90, has appropriate electromechanical or electro-optical switches to time sequence the switching of a fiber conduit 91 to any one of the 32 fibers coupled to the head 88. The system employs any one or more fibers for transmission and any other fibers for detection. An MRI/MOI control center 94 includes an imaging center 95 and a computer system 96, which is constructed to create and overlay the optical and magnetic images. Coordination of the optical and MRI images is achieved by MRI/optical markers. Three-dimensional markers are formed by coating the fibers with a film exhibiting a magnetically relaxed water-like signal so that each optical fiber appears on an NMR image. This way an optical image generated by the corresponding source and detector fibers is correlated to the MRI image. Importantly, such “labeled” fibers do not interfere with the NMR examination.
  • Imaging center 95 employs a TRS system described in U.S. Pat. No. 5,119,815 or in U.S. Pat. No. 5,386,827. The TRS system includes a Ti sapphire tunable laser that generates a series of light pulses of different wavelengths in the NIR region, sensitive to an endogenous or exogenous pigment. The light pulses, generated as shown in a timing diagram of FIG. 8A, are transmitted via fiber conduit 91 to fiber junction box 92. At fiber junction box 92, the signals are multiplexed to the 32 fibers that transmit light to and receive light from appropriate places in the brain. A single optical fiber may also be connected to fiber branches which are attached to various places on the head. The TRS system also includes two 8 multi-anode micro-channel plate detectors. The detector output is send to a parallel computer that generates images congruent with the MRI scan and completed in approximately the same time as the MRI data.
  • To achieve proper coupling, the fibers are indexed in space to form an array and are encoded appropriately by an index pad that mimics the tissue positions. This identifies the position of the fibers in the array 1 through 32 relative to a master synchronizing pulse. The imaging sequence consists of a series of pulses transmitted through the main fiber to an identified site at selected intervals (e.g., 5 nanosecond). Each pulse generates a photon migration pattern which is received through an identified optical coupling fiber and is recognized by the central computer as originating from a certain receiving fiber or set of receiving fibers by time encoding. The transmitter pulse stimulates all transmit fibers in sequence. Similarly, the pattern received is a composite of all receiver positions. The imaging console “knows” not only the location of the fiber, but also identifies the signal received from the fiber conduit by its time sequence with respect to the synchronizing pulse. The transmission/reception algorithm consists of a sequence of excitation pulses followed by photon diffusion patterns detected at the particular positions selected specifically for the organ being studied.
  • The system may use a generic transmission/reception algorithm designed for an average organ or a patient specific algorithm. Furthermore, different algorithms may be used for ipsilateral, contralateral, de novo or recurrent brain bleeding. The optical coupler can be attached to the head (or any part of the body) for longer periods of time to monitor evolution of a tissue state (e.g., brain bleeding, compartment syndrome, or changes in a stroke induced volume) during and after administration of a specific drug. For example, the system can also monitor evolution of a stroke induced volume or changes in intracranial pressure after administration of an osmotic agent (e.g., mannitol, glycerol), texamethasone (with its effects delayed for several hours) or another drug that temporarily reduces brain oedema. The system can also monitor evolution of a solute (e.g., glucose) as it equilibrates in the bloodstream.
  • Computer system 96 provides an overlay of the two images with contrast due to vascularity/vasculogenesis, blood vessels permeability, proliferation/degeneration of intracellular organelles, or some other tissue characteristics. To properly correlate the optical images to the NMR images, the optical images need to have an adequate contrast. The desired gradient of contrast is accomplished by selecting a suitable contrast agent (i.e., an exogenous pigment) and a wavelength of the introduced light. The spectrophotometer may construct separate images based on the scattering coefficient or the absorption coefficient. Furthermore, imaging center 95 may employ an amplitude modulation system or a CW system rather than the TRS system to increase resolution for some types of images.
  • Referring to FIGS. 9 and 9A, another embodiment of the optical coupling system a scanning coupler 160. Scanning coupler 160, constructed for imaging of breast tissue, employs a spectroscopic imaging system described in the WO 93/25145 application or in the PCT/US95/15694 application. Scanning system 160 includes an optical coupler 162, which may have cubical or cylindrical shape and is filled with optical medium 164. Optical coupler 162 is positioned over the breast near the chest wall. As described above, the optical properties, pressure and volume of medium 164 may be controlled by an external system connected to the coupler by a set of tubes. The optical matching fluid (e.g., twice-diluted J&J baby lotion) is contained within a pliable, optically transparent barrier. The inside walls of coupler 162 may be coated with a film that reflects light in the visible or near infra-red range back to the matching fluid to prevent escape of photons from the tissue surface. The optical coupler may be of different sizes or may have an adjustable volume so that the coupler can have a selected distance between the breast surface and the inside walls. (The preferred distance is about 1 centimeter, but for a very small tissue a larger distance is preferable to achieve semi-infinite boundary conditions.) Thus the coupler is also useful for examination of a small breast or after a surgical removal of the breast tissue. After placement of coupler 162, the volume of medium 164 is adjusted so that the barrier fits snugly around the examined breast. Alternatively, the optical medium is a pliable solid, for example, an absorbing gel containing metallic or oxide spherical particles, silky glass beads as scatterers or a suitable plastic material.
  • FIG. 9A depicts a set of couplers 162A and 162B for simultaneous scanning of both breasts. Attached to each coupler are source-detector probes (168A, 168B, 168C, 168D, 169A, 169B, 169C, 168D), which include one or more optical sources or detectors described above. The probes are movable on a rail 170. In an automatic positioning system, each probe is connected to a servo motor (step motor) that is operated by a controller. Depending on the spectroscopic system, a fiber 172 (of FIG. 9) may be used to collect, at a detection port 174, radiation that has migrated in the examined tissue and couple the radiation to a detector. Alternatively, fiber 172 may be used to couple, at input port 174, radiation to the examined tissue.
  • In an electro-optic scan, a computer controller maintains coordinated positions of the probes to the selected combination of the transmitters and receivers. The scan is performed on a single breast or simultaneously on the contralateral breast. The sensitivity of the simultaneous scan is increased by measuring a differential signal. A computer displays the detected signal or the differential signal in a 3 dimensional coordinate system. To increase the resolution, a contrast agent (e.g., cardio-green, indocyanine-green) which is preferentially accumulated in a tumor may by injected intravenously. Several scans are performed to observe the time dependence of the decay and identify a location of a suspected anomaly. The system can also calculate the scattering coefficient and absorption coefficient of the suspected anomaly and the surrounding tissue.
  • Referring to FIGS. 10 and 10A, in another embodiment, an optical coupler 181 is located at a distal end of a catheter 180. Catheter 180 includes at least two optical conduits 184 and 190, which are at the proximal end connected to a fiber junction box 182 (e.g., a muliplexer, a sequencer). The optical coupler includes at least one input port 186 and at least one detection port 192, separated by a selected distance, and an optical barrier 189 constructed to prevent direct migration of the radiation between the ports. Input port 186 and detection port 192 may also include selected optical medium 188 and 194, respectively. Prior to the spectroscopic examination, optical conduits 184 and 190 may be used for illumination and observation of the internal tissue. At the distal end, catheter 180 may include an inflatable balloon 183. When inflated, balloon 183 presses the optical ports 186 and 192, or pliable optical medium 188 and 194 to the examined tissue.
  • Alternatively, catheter 180 may include, at its distal end, an optical coupler 200, shown in FIG. 10B, which is constructed and arranged for examination or long term monitoring of brain tissue (or another tissue) of a fetus still located in the uterus. Optical coupler 200 includes a suction ring 202 (or a suction cup) constructed to maintain optical ports 204 and 206 at a selected position, and optical medium 194. Catheter 180 is introduced to the uterus either through the birth canal or through the maternal abdominal wall.
  • Alternatively, optical coupler 200 designed for visual and spectroscopic examination selected internal tissue, for example, cervix, uterus, gastrointestinal tract, urinary tract, bronchi, and other. Catheter 180 is introduced to the selected tissue region via a body passage or transcutaneously. Optical conduits 184 and 190 are first utilized to locate, visualize and examine the internal tissue by a clinician. If the clinician locates a tissue region that requires further examination, he/she positions the optical input and detection ports for spectroscopic examination utilizing a spectrophotometer optically coupled to the proximal end of catheter 180. The spectroscopic examination is performed by detecting back-scattered light that has migrated from the input port to the detection port, or by detecting fluorescent light excited in the examined tissue. Depending on the type of examination, the spectrophotometer is the above-cited CWS, TRS, PMS or phased array spectrophotometer, or a spectrophotometer described in U.S. Pat. No. 4,930,516, 5,042,494, 5,106,387, 5,131,398, or 5,261,410.
  • Catheter 180 may also include a biopsy attachment for taking a biopsy specimen from a tissue region previously examined by the spectrophotometer. The biopsy is performed only if the spectroscopic examination indicates a potentially abnormal tissue. Thus the initial spectroscopic examination eliminates a substantial number of biopsies and saves the related cost.
  • Referring to FIGS. 11 and 11A, in another embodiment, a spectrophotometer is disposed on a catheter 210 (e.g., an endoscopic catheter), which may include an inflatable balloon 212 and endoscope optics 214. The spectrophotometer (e.g., a TRS-pulse, PMS, CW, or phased array spectrophotometer) includes light sources 216 and 218 movable on tracks 217 and 219, respectively, and centrally located detectors 220 and 222. Optical medium 224 is at least partially surrounding the sources and the detectors. In operation, catheter 210, with the balloon deflated, is passed through a body lumen to the position of interest, guided for example, by fluorimetry or by endoscopic viewing. The balloon is then inflated to press optical medium 224 against the tissue of interest. The technique and apparatus may be applied, for example, to body lumens such as the GI tract (e.g., for measurements of GI track wall) or to blood vessels, employing an angiographic catheter for analysis and treatment of occlusions.
  • A comprehensive system can serve many hospital functions including transduction of vital signals from bedside, from the OR, the ICU, or the ER to a designated computer. The system may include a large number of optrode transducers which may measure all the vital signs (blood pressure, pulse, temperature, respiration) electrocardiogram, electroencephalogram, serum electrolyte levels, and all the features of medical optical imaging (e.g., the simplest detection of hemorrhage, oxygen saturation of hemoglobin, imaging of potential dangers such as stroke, aneurysm rupture, and recurrence of brain bleeding). This information could be carried by single optical fibers with suitable transduction to whatever transmission method is optimal including highly sophisticated PCM.
  • Other embodiment are within the following claims:

Claims (13)

1-34. (canceled)
35. A spectrophotometric system for examination of biological tissue of interest using visible or infra-red radiation scattered over photon migration paths in the tissue, comprising:
a light source constructed and arranged to emit a light beam of visible or infra-red radiation;
a light coupling system, including at least one mirror, constructed and arranged to receive said emitted light beam, and constructed to scan said received light beam and direct said scanned light beam directly into the biological tissue of interest;
a light detector optically coupled to detect photons of radiation that have migrated over optical paths in the biological tissue of interest; and
a processor, operatively coupled to said light source and detector, adapted to determine an optical property of the biological tissue of interest based on the changes between said introduced radiation in form of said directed light beam and said detected radiation that have migrated over photon migration paths in the biological tissue of interest.
36. The spectrophotometric system of claim 35 constructed and arranged as a time resolved spectrophotometric unit, wherein said light source is constructed to emit radiation comprises radiation pulses on the order of a nanosecond or less.
37. The spectrophotometric system of claim 35 constructed and arranged as a continuous wave spectrophotometer, wherein said light source is constructed to emit continuous wave, low modulation frequency radiation.
38. The spectrophotometric system of claim 35 constructed and arranged as a phase modulation spectrophotometric unit, wherein said light source is constructed to emit radiation that is modulated by a carrier waveform of a frequency on the order of 108 Hz.
39. The spectrophotometric system of claim 38, wherein said light detector is a photomultiplier tube.
40. The spectrophotometric system of claim 35, wherein said light includes a laser.
41. The spectrophotometric system of claim 35, wherein said light detector includes a photomultiplier tube.
42. The spectrophotometric system of claim 35, wherein said light detector includes a diode detector.
43. A spectrophotometric system for examination of biological tissue by migration of photons scattered and absorbed over photon migration paths inside the examined tissue, comprising:
a laser source constructed and arranged to emit a laser beam of visible or infra-red radiation;
a light detector optically coupled to detect photons that have migrated over optical scatter paths in the examined biological tissue;
an ultrasound system constructed and arranged to deliver ultrasound to and receive ultrasound from the examined biological tissue; and
a processor adapted to determine an optical property of the examined biological tissue based on the changes between said radiation introduced in form of said directed laser beam and said detected radiation that have migrated and scattered over photon migration paths inside the examined biological tissue.
44. A spectrophotometric system for examination of biological tissue by migration of photons scattered and absorbed over photon migration paths inside the examined tissue, comprising:
a laser source constructed and arranged to emit a laser beam of visible or infra-red radiation;
a rotating mirror constructed and arranged to receive said emitted light beam, and direct the laser beam into the examined biological tissue;
a light detector optically coupled to detect photons that have migrated over optical scatter paths in the examined biological tissue; and
a processor adapted to determine an optical property of the examined biological tissue based on the changes between said radiation introduced in form of said directed laser beam and said detected radiation that have migrated and scattered over photon migration paths inside the examined biological tissue.
45. The spectrophotometric system of claim 44, wherein said light includes a laser.
46. The spectrophotometric system of claim 44, wherein said light detector includes a diode detector.
US12/082,344 1988-11-02 2008-02-29 Optical coupler for in vivo examination of biological tissue Abandoned US20090030327A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US08/367,939 US5596987A (en) 1988-11-02 1995-01-03 Optical coupler for in vivo examination of biological tissue
PCT/US1996/000235 WO1996020638A1 (en) 1995-01-03 1996-01-02 Optical coupler for in vivo examination of biological tissue
US08/860,789 US5987351A (en) 1995-01-03 1997-10-06 Optical coupler for in vivo examination of biological tissue
US09/440,922 US6526309B1 (en) 1995-01-03 1999-11-16 Transcranial in vivo examination of brain tissue
US10/373,665 US20040054290A1 (en) 1995-01-03 2003-02-24 Spectrophotometer for in vivo examination of biological tissue
US11/437,766 US20060241502A1 (en) 1995-01-03 2006-05-18 Optical coupler for in vivo examination of biological tissue
US12/082,344 US20090030327A1 (en) 1995-01-03 2008-02-29 Optical coupler for in vivo examination of biological tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/082,344 US20090030327A1 (en) 1995-01-03 2008-02-29 Optical coupler for in vivo examination of biological tissue

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/437,766 Continuation US20060241502A1 (en) 1988-11-02 2006-05-18 Optical coupler for in vivo examination of biological tissue

Publications (1)

Publication Number Publication Date
US20090030327A1 true US20090030327A1 (en) 2009-01-29

Family

ID=23449241

Family Applications (5)

Application Number Title Priority Date Filing Date
US08/860,789 Expired - Lifetime US5987351A (en) 1988-11-02 1997-10-06 Optical coupler for in vivo examination of biological tissue
US09/440,922 Expired - Lifetime US6526309B1 (en) 1988-11-02 1999-11-16 Transcranial in vivo examination of brain tissue
US10/373,665 Abandoned US20040054290A1 (en) 1988-11-02 2003-02-24 Spectrophotometer for in vivo examination of biological tissue
US11/437,766 Abandoned US20060241502A1 (en) 1988-11-02 2006-05-18 Optical coupler for in vivo examination of biological tissue
US12/082,344 Abandoned US20090030327A1 (en) 1988-11-02 2008-02-29 Optical coupler for in vivo examination of biological tissue

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US08/860,789 Expired - Lifetime US5987351A (en) 1988-11-02 1997-10-06 Optical coupler for in vivo examination of biological tissue
US09/440,922 Expired - Lifetime US6526309B1 (en) 1988-11-02 1999-11-16 Transcranial in vivo examination of brain tissue
US10/373,665 Abandoned US20040054290A1 (en) 1988-11-02 2003-02-24 Spectrophotometer for in vivo examination of biological tissue
US11/437,766 Abandoned US20060241502A1 (en) 1988-11-02 2006-05-18 Optical coupler for in vivo examination of biological tissue

Country Status (7)

Country Link
US (5) US5987351A (en)
EP (2) EP0808124B1 (en)
JP (1) JP3725156B2 (en)
CN (1) CN1230118C (en)
CA (1) CA2209240C (en)
DE (1) DE69627477T2 (en)
WO (2) WO1996020638A1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080077198A1 (en) * 2006-09-21 2008-03-27 Aculight Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US20100004518A1 (en) * 2008-07-03 2010-01-07 Masimo Laboratories, Inc. Heat sink for noninvasive medical sensor
US20100030039A1 (en) * 2008-08-04 2010-02-04 Masimo Laboratories, Inc. Multi-stream sensor front ends for noninvasive measurement of blood constituents
US7736382B2 (en) 2005-09-09 2010-06-15 Lockheed Martin Corporation Apparatus for optical stimulation of nerves and other animal tissue
US7883536B1 (en) 2007-01-19 2011-02-08 Lockheed Martin Corporation Hybrid optical-electrical probes
US8012189B1 (en) 2007-01-11 2011-09-06 Lockheed Martin Corporation Method and vestibular implant using optical stimulation of nerves
US20130123643A1 (en) * 2010-04-12 2013-05-16 Holger Jungmann Measuring arrangement for recording a spectrum, in particular from vital tissue
US8475506B1 (en) 2007-08-13 2013-07-02 Lockheed Martin Corporation VCSEL array stimulator apparatus and method for light stimulation of bodily tissues
US8498699B2 (en) 2008-10-03 2013-07-30 Lockheed Martin Company Method and nerve stimulator using simultaneous electrical and optical signals
US20130248695A1 (en) * 2010-10-29 2013-09-26 Duncan MacIntyre Method and apparatus for analyte detection
US8652187B2 (en) 2010-05-28 2014-02-18 Lockheed Martin Corporation Cuff apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves
US8709078B1 (en) 2011-08-03 2014-04-29 Lockheed Martin Corporation Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light
US8747447B2 (en) 2011-07-22 2014-06-10 Lockheed Martin Corporation Cochlear implant and method enabling enhanced music perception
US8945197B1 (en) 2005-10-24 2015-02-03 Lockheed Martin Corporation Sight-restoring visual prosthetic and method using infrared nerve-stimulation light
US8956396B1 (en) 2005-10-24 2015-02-17 Lockheed Martin Corporation Eye-tracking visual prosthetic and method
US8996131B1 (en) 2006-09-28 2015-03-31 Lockheed Martin Corporation Apparatus and method for managing chronic pain with infrared light sources and heat
US9186102B2 (en) 2009-09-03 2015-11-17 Cercacor Laboratories, Inc. Emitter driver for noninvasive patient monitor

Families Citing this family (149)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6618614B1 (en) 1995-01-03 2003-09-09 Non-Invasive Technology, Inc. Optical examination device, system and method
CA2209240C (en) * 1995-01-03 2009-07-21 Non-Invasive Technology, Inc. Optical coupler for in vivo examination of biological tissue
US5353799A (en) 1991-01-22 1994-10-11 Non Invasive Technology, Inc. Examination of subjects using photon migration with high directionality techniques
US6397099B1 (en) 1992-05-18 2002-05-28 Non-Invasive Technology, Inc. Non-invasive imaging of biological tissue
US5987346A (en) * 1993-02-26 1999-11-16 Benaron; David A. Device and method for classification of tissue
US20060184046A1 (en) * 1995-10-06 2006-08-17 Yuichi Yamashita Optical measurement instrument for living body
US6240309B1 (en) * 1995-10-06 2001-05-29 Hitachi, Ltd. Optical measurement instrument for living body
US5803909A (en) * 1994-10-06 1998-09-08 Hitachi, Ltd. Optical system for measuring metabolism in a body and imaging method
US20050043596A1 (en) * 1996-07-12 2005-02-24 Non-Invasive Technology, Inc., A Delaware Corporation Optical examination device, system and method
US6152876A (en) * 1997-04-18 2000-11-28 Rio Grande Medical Technologies, Inc. Method for non-invasive blood analyte measurement with improved optical interface
US20060184047A1 (en) * 1995-11-17 2006-08-17 Yuichi Yamashita Optical measurement instrument for living body
US5853370A (en) 1996-09-13 1998-12-29 Non-Invasive Technology, Inc. Optical system and method for non-invasive imaging of biological tissue
WO1998044839A1 (en) * 1997-04-03 1998-10-15 National Research Council Of Canada Method of assessing tissue viability using near-infrared spectroscopy
JP4166282B2 (en) 1997-05-09 2008-10-15 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Device for positioning an object in a turbid medium
US6675035B1 (en) * 1997-06-20 2004-01-06 Imaging Diagnostic Systems, Inc. Phantom for optical and magnetic resonance imaging quality control
DE69943188D1 (en) * 1999-06-03 2011-03-24 Hamamatsu Photonics Kk Optical ct device and method for recovering images
EP1054619B1 (en) * 1998-02-11 2007-11-21 Non-Invasive Technology, Inc. Imaging and characterization of brain tissue
CA2319454C (en) 1998-02-11 2010-04-27 Non-Invasive Technology, Inc. Detection, imaging and characterization of breast tumors
DE69941975D1 (en) 1998-02-13 2010-03-18 Non Invasive Technology Inc Investigation, observation and image display of abdominal tissue
JP4006826B2 (en) 1998-04-28 2007-11-14 株式会社日立メディコ Biological light measurement device
US6592847B1 (en) * 1998-05-14 2003-07-15 The General Hospital Corporation Intramolecularly-quenched near infrared flourescent probes
EP1085835A4 (en) * 1998-06-19 2002-10-30 Uab Research Foundation Oximetric tonometer with intracranial pressure monitoring capability
AU8558598A (en) 1998-07-30 2000-02-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Optical mammography
US7904139B2 (en) 1999-08-26 2011-03-08 Non-Invasive Technology Inc. Optical examination of biological tissue using non-contact irradiation and detection
US6949081B1 (en) 1998-08-26 2005-09-27 Non-Invasive Technology, Inc. Sensing and interactive drug delivery
US6741884B1 (en) 1998-09-03 2004-05-25 Hypermed, Inc. Infrared endoscopic balloon probes
WO2000013578A1 (en) * 1998-09-03 2000-03-16 Hypermed Imaging, Inc. Infrared endoscopic balloon probes
US8024027B2 (en) 1998-09-03 2011-09-20 Hyperspectral Imaging, Inc. Infrared endoscopic balloon probes
EP1121048A4 (en) * 1998-10-13 2003-06-25 Somanetics Corp Multi-channel non-invasive tissue oximeter
USRE44735E1 (en) 1998-10-13 2014-01-28 Covidien Lp Multi-channel non-invasive tissue oximeter
DE69929380T2 (en) 1998-12-07 2006-08-31 Hitachi, Ltd. Device for controlling plants by means of body signals
US7047054B2 (en) * 1999-03-12 2006-05-16 Cas Medical Systems, Inc. Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring
EP1079725B1 (en) * 1999-03-23 2007-05-23 Philips Electronics N.V. Device for localizing an object in a turbid medium
WO2000057793A1 (en) * 1999-03-29 2000-10-05 Hitachi Medical Corporation Biological optical measuring instrument
IL129398A (en) * 1999-04-12 2005-05-17 Israel Atomic Energy Comm Metabolism monitoring or body organs
US6167297A (en) 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
JP2003508734A (en) * 1999-08-31 2003-03-04 シーエムイー テレメトリックス インク. Apparatus for verifying the accuracy of the spectral analyzer
AU7579300A (en) * 1999-09-14 2001-04-17 Research Foundation of State University of New York, Technology Transfer Office, The Method and system for imaging the dynamics of scattering medium
US7280866B1 (en) 1999-10-06 2007-10-09 National Research Council Of Canada Non-invasive screening of skin diseases by visible/near-infrared spectroscopy
DE19954756A1 (en) * 1999-11-17 2001-05-31 Odim Gmbh Device and method for the examination of biological tissue
US7006676B1 (en) 2000-01-21 2006-02-28 Medical Optical Imaging, Inc. Method and apparatus for detecting an abnormality within a host medium utilizing frequency-swept modulation diffusion tomography
CA2398278C (en) 2000-01-27 2012-05-15 National Research Council Of Canada Visible-near infrared spectroscopy in burn injury assessment
DE10004989B4 (en) * 2000-02-04 2006-11-02 Siemens Ag Method and device for arthritis diagnosis
US6516209B2 (en) 2000-08-04 2003-02-04 Photonify Technologies, Inc. Self-calibrating optical imaging system
US6801648B2 (en) 2000-08-04 2004-10-05 Xuefeng Cheng Optical imaging system with symmetric optical probe
US6719686B2 (en) * 2000-08-30 2004-04-13 Mallinckrodt, Inc. Fetal probe having an optical imaging device
US6587703B2 (en) 2000-09-18 2003-07-01 Photonify Technologies, Inc. System and method for measuring absolute oxygen saturation
US6597931B1 (en) 2000-09-18 2003-07-22 Photonify Technologies, Inc. System and method for absolute oxygen saturation
US7383076B2 (en) * 2000-11-27 2008-06-03 The General Hospital Corporation Fluorescence-mediated molecular tomography
US6826424B1 (en) * 2000-12-19 2004-11-30 Haishan Zeng Methods and apparatus for fluorescence and reflectance imaging and spectroscopy and for contemporaneous measurements of electromagnetic radiation with multiple measuring devices
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
DE10109539A1 (en) * 2001-02-28 2002-09-12 Siemens Ag Device for examining tissue with light
WO2002097404A1 (en) * 2001-05-30 2002-12-05 Sciperio, Inc. System, method, and apparatus for non-intrusively determining concentration of a solute in a solution
US6659941B2 (en) * 2001-06-19 2003-12-09 Mallinckrodt, Inc. Balloon assisted endoscope for viewing a fetus during delivery
US7047057B2 (en) * 2001-07-16 2006-05-16 Art. Advanced Research Technologies Inc. Simultaneous multiwavelength TPSF-based optical imaging
US20030062485A1 (en) * 2001-09-28 2003-04-03 Fernandez Salvador M. Compact multiwavelength phase fluorometer
US20050107709A1 (en) * 2002-04-02 2005-05-19 Technische Universitat Dresden Method and arrangement for optically measuring swelling of the nose
WO2003102558A1 (en) 2002-06-04 2003-12-11 Visen Medical, Inc. Imaging volumes with arbitrary geometries in contact and non-contact tomography
US7840257B2 (en) 2003-01-04 2010-11-23 Non Invasive Technology, Inc. Examination of biological tissue using non-contact optical probes
WO2004010844A2 (en) 2002-07-26 2004-02-05 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring
US8412297B2 (en) 2003-10-01 2013-04-02 Covidien Lp Forehead sensor placement
US7698909B2 (en) 2002-10-01 2010-04-20 Nellcor Puritan Bennett Llc Headband with tension indicator
DE60334007D1 (en) 2002-10-01 2010-10-14 Nellcor Puritan Bennett Inc Use of headband for voltage indication and system of oximeter and headband
WO2004065943A1 (en) * 2003-01-22 2004-08-05 Art, Advanced Research Technologies, Inc. Simultaneous acquisition of different time-gates in tpsf-based optical imaging
US7647091B2 (en) * 2003-02-05 2010-01-12 The General Hospital Corporation Method and system for free space optical tomography of diffuse media
CN100557420C (en) * 2003-02-06 2009-11-04 皇家飞利浦电子股份有限公司 Apparatus and method for blood analysis
US7047056B2 (en) * 2003-06-25 2006-05-16 Nellcor Puritan Bennett Incorporated Hat-based oximeter sensor
US6949072B2 (en) * 2003-09-22 2005-09-27 Infraredx, Inc. Devices for vulnerable plaque detection
US7491169B2 (en) 2004-03-22 2009-02-17 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Ultrasonic apparatus and method to assess compartment syndrome
US8060172B2 (en) * 2004-03-29 2011-11-15 Olympus Corporation In-vivo information measurement apparatus
US7570979B2 (en) * 2004-03-30 2009-08-04 Philip George Cooper Methods and apparatus for patient monitoring
US7313425B2 (en) * 2004-07-08 2007-12-25 Orsense Ltd. Device and method for non-invasive optical measurements
US7381186B2 (en) * 2004-08-02 2008-06-03 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method and apparatus to assess compartment syndrome
CA2520602A1 (en) * 2004-09-21 2006-03-21 Art Recherches Et Technologies Avancees Inc./Art Advanced Research Techn Method for selecting wavelengths for optical data acquisition
US8062224B2 (en) * 2004-10-28 2011-11-22 Uab Vittamed Method and apparatus for non-invasive continuous monitoring of cerebrovascular autoregulation state
US7298009B2 (en) * 2005-02-01 2007-11-20 Infineon Technologies Ag Semiconductor method and device with mixed orientation substrate
ES2642853T3 (en) * 2012-02-27 2017-11-20 Apd Advanced Perfusion Diagnostics Apparatus and method for measuring blood flow within the gastrointestinal tract
WO2006121833A2 (en) 2005-05-06 2006-11-16 Infrascan Inc. System and method for detection of hematoma
WO2006124696A1 (en) * 2005-05-13 2006-11-23 Children's Hospital Medical Center Multi-wavelength spatial domain near infrared oximeter to detect cerebral hypoxia-ischemia
US20070093708A1 (en) * 2005-10-20 2007-04-26 Benaron David A Ultra-high-specificity device and methods for the screening of in-vivo tumors
US7802690B2 (en) * 2005-10-24 2010-09-28 Portola Packaging, Inc. Closure having expanded peripheral surface
WO2007060586A2 (en) * 2005-11-23 2007-05-31 Koninklijke Philips Electronics N.V. Method and device for optical imaging of a turbid medium
US7559945B2 (en) 2006-01-13 2009-07-14 Clarimedix Inc. Multi-spectral photon therapy device and methods of use
US20090306533A1 (en) * 2006-01-26 2009-12-10 Rousche Patrick J Stroke Inducing and Monitoring System and Method for Using the Same
WO2007109124A2 (en) * 2006-03-16 2007-09-27 The Trustees Of Boston University Electro-optical sensor for peripheral nerves
US20070282404A1 (en) * 2006-04-10 2007-12-06 University Of Rochester Side-firing linear optic array for interstitial optical therapy and monitoring using compact helical geometry
CN101511263B (en) * 2006-09-07 2011-11-23 皇家飞利浦电子股份有限公司 Optical tomography measurement using an adapted brim for the receiving volume
US8116852B2 (en) 2006-09-29 2012-02-14 Nellcor Puritan Bennett Llc System and method for detection of skin wounds and compartment syndromes
WO2008053405A1 (en) * 2006-10-30 2008-05-08 Koninklijke Philips Electronics N.V. Imaging of turbid medium
RU2009123019A (en) * 2006-11-17 2010-12-27 Кониклейке Филипс Электроникс Н.В. (Nl) Device for obtaining images of the internal area of a murdy environment
US7936459B1 (en) * 2006-11-21 2011-05-03 David Coombs Apparatus with probe
US7983740B2 (en) * 2006-12-22 2011-07-19 Washington University High performance imaging system for diffuse optical tomography and associated method of use
US8100834B2 (en) 2007-02-27 2012-01-24 J&M Shuler, Inc. Method and system for monitoring oxygenation levels of a compartment for detecting conditions of a compartment syndrome
US8639309B2 (en) 2007-07-31 2014-01-28 J&M Shuler, Inc. Method and system for monitoring oxygenation levels of compartments and tissue
US20080228053A1 (en) * 2007-03-15 2008-09-18 Shih-Ping Wang Method and system for cerebral oxygenation level monitoring
US9226731B2 (en) * 2007-05-21 2016-01-05 The Board Of Regents Of The University Of Texas System Optically guided needle biopsy system using multi-modal spectroscopy in combination with a transrectal ultrasound probe
EP2040050B1 (en) * 2007-09-24 2012-03-07 Universität Potsdam Measuring assembly for an optical spectrometer
CN101827556B (en) 2007-10-19 2013-06-19 皇家飞利浦电子股份有限公司 Device for imaging the interior of an optically turbid medium and receptacle unit for such a device
JP5420163B2 (en) * 2007-10-24 2014-02-19 浜松ホトニクス株式会社 Biological measuring device
US8380272B2 (en) * 2007-12-21 2013-02-19 Covidien Lp Physiological sensor
ES2658852T3 (en) 2008-01-18 2018-03-12 Visen Medical, Inc. Fluorescent imaging agents
DE102008011013B4 (en) * 2008-02-25 2014-11-13 Mevitec Gmbh Method and device for complex metabolic analysis
US8243071B2 (en) * 2008-02-29 2012-08-14 Microsoft Corporation Modeling and rendering of heterogeneous translucent materials using the diffusion equation
US20090234245A1 (en) * 2008-03-17 2009-09-17 O2 Medtech, Inc. Non-invasive monitoring of intracranial pressure
US9480425B2 (en) * 2008-04-17 2016-11-01 Washington University Task-less optical mapping of dynamic brain function using resting state functional connectivity
PT2291640T (en) 2008-05-20 2019-02-26 Univ Health Network Device and method for fluorescence-based imaging and monitoring
US20100016731A1 (en) * 2008-07-15 2010-01-21 Cardiox Corporation Hemodynamic Detection of Circulatory Anomalies
US8353833B2 (en) 2008-07-18 2013-01-15 University Of Rochester Low-cost device for C-scan photoacoustic imaging
DE102008050109B4 (en) * 2008-07-21 2010-06-17 Ancosys Gmbh Optical sensor
ES2694278T3 (en) * 2008-09-18 2018-12-19 Cedars-Sinai Medical Center Optical method for the detection of Alzheimer's disease
US8257274B2 (en) 2008-09-25 2012-09-04 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
WO2010035207A2 (en) 2008-09-26 2010-04-01 Koninklijke Philips Electronics N.V. Detection chamber with variable volume
WO2010058339A2 (en) * 2008-11-21 2010-05-27 Koninklijke Philips Electronics N.V. Imaging a turbid medium
WO2010061339A1 (en) * 2008-11-26 2010-06-03 Koninklijke Philips Electronics N.V. Device and method for optically examining the interior of a turbid medium
US8515515B2 (en) 2009-03-25 2013-08-20 Covidien Lp Medical sensor with compressible light barrier and technique for using the same
US8781548B2 (en) 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
US20120095305A1 (en) * 2009-06-15 2012-04-19 O2 Medtech, Inc. Spectrophotometric Monitoring Of Multiple Layer Tissue Structures
US9693717B2 (en) 2009-07-10 2017-07-04 Cas Medical Systems, Inc. Method for spectrophotometric blood oxygenation monitoring of the lower gastrointestinal tract
FR2950431B1 (en) 2009-09-24 2011-12-09 Commissariat Energie Atomique Device and method for spatial reconstruction of fluorescence cartography
FR2951283B1 (en) * 2009-10-08 2013-02-15 Commissariat Energie Atomique Method and device for diffused excitation in imaging
EP2501288B1 (en) 2009-11-19 2016-12-21 Modulated Imaging Inc. Method and apparatus for analysis of turbid media via single-element detection using structured illumination
US10314650B2 (en) 2010-06-16 2019-06-11 Biosense Webster (Israel) Ltd. Spectral sensing of ablation
US8648321B2 (en) 2010-07-05 2014-02-11 Emz-Hanauer Gmbh & Co. Kgaa Optical sensor for use in a domestic washing machine or dishwasher
DE102010026068B4 (en) 2010-07-05 2017-09-28 Emz-Hanauer Gmbh & Co. Kgaa Optical sensor, in particular for installation in a washing machine or a dishwasher of household equipment
JP5865909B2 (en) * 2010-09-07 2016-02-17 シーエヌシステムズ メディジンテクニク アクチェンゲゼルシャフト Disposable and removable sensor for continuous non-invasive arterial blood pressure monitoring
US9775545B2 (en) 2010-09-28 2017-10-03 Masimo Corporation Magnetic electrical connector for patient monitors
US8821397B2 (en) 2010-09-28 2014-09-02 Masimo Corporation Depth of consciousness monitor including oximeter
AU2011323310A1 (en) 2010-11-03 2013-06-13 University Of Washington Through Its Center For Commercialization Determination of tissue oxygenation in vivo
FR2968921B1 (en) 2010-12-15 2013-01-11 Commissariat Energie Atomique Method for locating an optical marker in a diffusing medium
CN102551736A (en) * 2012-01-19 2012-07-11 西北工业大学 Light sensing system
WO2013134949A1 (en) * 2012-03-16 2013-09-19 西安电子科技大学 Device and method for endoscopic x ray luminescence tomography imaging
WO2013186780A1 (en) 2012-06-13 2013-12-19 Hadasit Medical Research Services And Development Ltd. Devices and methods for detection of internal bleeding and hematoma
US20140046170A1 (en) * 2012-08-07 2014-02-13 Chia-Wei Sun Brain volumetric measuring method and system using the same
US20140051975A1 (en) * 2012-08-15 2014-02-20 Aspect Imaging Ltd. Multiple heterogeneous imaging systems for clinical and preclinical diagnosis
JP6321668B2 (en) 2012-11-07 2018-05-09 モデュレイテッド イメージング, インコーポレイテッド Efficient modulation imaging
US9256963B2 (en) 2013-04-09 2016-02-09 Elc Management Llc Skin diagnostic and image processing systems, apparatus and articles
US9101320B2 (en) 2013-04-09 2015-08-11 Elc Management Llc Skin diagnostic and image processing methods
DE102013010611A1 (en) * 2013-06-25 2015-01-08 Sms Swiss Medical Sensor Ag Measuring device and measuring method for measuring raw data for determining a blood parameter, in particular for noninvasive determination of the D-glucose concentration
USD763938S1 (en) 2014-04-02 2016-08-16 Cephalogics, LLC Optical sensor array
USD763939S1 (en) 2014-04-02 2016-08-16 Cephalogics, LLC Optical sensor array liner with optical sensor array pad
WO2016011534A1 (en) 2014-07-24 2016-01-28 University Health Network Collection and analysis of data for diagnostic purposes
US10154815B2 (en) 2014-10-07 2018-12-18 Masimo Corporation Modular physiological sensors
JP6555503B2 (en) * 2015-01-13 2019-08-07 株式会社リコー Optical sensor, optical inspection apparatus, and optical property detection method
ES2588017B1 (en) * 2015-04-27 2017-08-02 Universidad Miguel Hernández De Elche A device suitable for the collection of data in a record of neuronal activity
US10448871B2 (en) * 2015-07-02 2019-10-22 Masimo Corporation Advanced pulse oximetry sensor
DE102017116308A1 (en) * 2017-07-19 2019-01-24 Osram Opto Semiconductors Gmbh Optoelectronic sensor
WO2019051223A1 (en) * 2017-09-07 2019-03-14 Arizona Board Of Regents On Behalf Of The University Of Arizona Imaging electrical current patterns generated by a medical device
EP3473172A1 (en) * 2017-10-20 2019-04-24 Universität Zürich Apparatus for measuring optical parameters in scattering media

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945239A (en) * 1989-03-29 1990-07-31 Center For Innovative Technology Early detection of breast cancer using transillumination
US4972331A (en) * 1989-02-06 1990-11-20 Nim, Inc. Phase modulated spectrophotometry
US5007428A (en) * 1987-04-21 1991-04-16 The University Court Of The University Of Aberdeen Apparatus for examining a body of living tissues
US5119815A (en) * 1988-12-21 1992-06-09 Nim, Incorporated Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation
US5386827A (en) * 1993-03-30 1995-02-07 Nim Incorporated Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy
US5398685A (en) * 1992-01-10 1995-03-21 Wilk; Peter J. Endoscopic diagnostic system and associated method
US5555885A (en) * 1988-12-21 1996-09-17 Non-Invasive Technology, Inc. Examination of breast tissue using time-resolved spectroscopy
US5596987A (en) * 1988-11-02 1997-01-28 Noninvasive Technology, Inc. Optical coupler for in vivo examination of biological tissue

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3068742A (en) * 1959-06-15 1962-12-18 American Optical Corp Means for performing colorimetry
US3412729A (en) * 1965-08-30 1968-11-26 Nasa Usa Method and apparatus for continuously monitoring blood oxygenation, blood pressure, pulse rate and the pressure pulse curve utilizing an ear oximeter as transducer
US3461856A (en) * 1965-10-23 1969-08-19 American Optical Corp Oximeters
US3638640A (en) * 1967-11-01 1972-02-01 Robert F Shaw Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths
US3709612A (en) * 1971-03-10 1973-01-09 Miles Lab Apparatus for measuring reflected light under stabilized light source conditions
US3866599A (en) * 1972-01-21 1975-02-18 Univ Washington Fiberoptic catheter
CH581836A5 (en) * 1974-08-20 1976-11-15 Contraves Ag
JPS5725217B2 (en) * 1974-10-14 1982-05-28
CA1037285A (en) * 1975-04-30 1978-08-29 Glenfield Warner Ear oximetry process and apparatus
US4119406A (en) * 1976-05-06 1978-10-10 Miles Laboratories, Inc. Calibration apparatus
US4416285A (en) * 1978-11-29 1983-11-22 Oximetrix, Inc. Improved optical catheter and method for making same
US4167331A (en) * 1976-12-20 1979-09-11 Hewlett-Packard Company Multi-wavelength incremental absorbence oximeter
US4086652A (en) * 1977-01-19 1978-04-25 Block Engineering, Inc. Method and apparatus for analyzing a time-dependent phenomenon
US4281645A (en) * 1977-06-28 1981-08-04 Duke University, Inc. Method and apparatus for monitoring metabolism in body organs
US4162405A (en) * 1978-05-23 1979-07-24 Britton Chance Flying spot fluoro-meter for oxidized flavoprotein and reduced pyridine nucleotide
US4515165A (en) * 1980-02-04 1985-05-07 Energy Conversion Devices, Inc. Apparatus and method for detecting tumors
US4485820A (en) * 1982-05-10 1984-12-04 The Johns Hopkins University Method and apparatus for the continuous monitoring of hemoglobin saturation in the blood of premature infants
DE3323365C2 (en) * 1982-09-04 1994-10-20 Gsf Forschungszentrum Umwelt Method and apparatus for illumination of cavities
IT1206462B (en) * 1984-08-07 1989-04-27 Anic Spa Photometer pulsed light in multiple wavelength for non-invasive monitoring.
DD227044B1 (en) * 1984-10-11 1990-10-10 Akad Wissenschaften Ddr Device for detecting the metabolism condition of living organs
US5106387A (en) * 1985-03-22 1992-04-21 Massachusetts Institute Of Technology Method for spectroscopic diagnosis of tissue
US4824242A (en) * 1986-09-26 1989-04-25 Sensormedics Corporation Non-invasive oximeter and method
DE3872545D1 (en) * 1987-02-23 1992-08-13 Sumitomo Electric Industries DEVICE FOR MEASURING A tissue metabolism.
JPS63277039A (en) * 1987-05-08 1988-11-15 Hamamatsu Photonics Kk Diagnostic apparatus
US4805623A (en) * 1987-09-04 1989-02-21 Vander Corporation Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment
US4800885A (en) * 1987-12-02 1989-01-31 The Boc Group, Inc. Blood constituent monitoring apparatus and methods with frequency division multiplexing
US4846183A (en) * 1987-12-02 1989-07-11 The Boc Group, Inc. Blood parameter monitoring apparatus and methods
CA2209240C (en) * 1995-01-03 2009-07-21 Non-Invasive Technology, Inc. Optical coupler for in vivo examination of biological tissue
US5187672A (en) * 1989-02-06 1993-02-16 Nim Incorporated Phase modulation spectroscopic system
US5090415A (en) * 1989-02-14 1992-02-25 Hamamatsu Photonics Kabushiki Kaisha Examination apparatus
JP2798450B2 (en) * 1989-12-08 1998-09-17 株式会社日立製作所 Living body measuring device
US5300097A (en) * 1991-02-13 1994-04-05 Lerner Ethan A Fiber optic psoriasis treatment device
DE69229554D1 (en) * 1991-05-16 1999-08-12 Non Invasive Technology Inc Hemoglobin measurement for determination of metabolic parameters of a person
US6397099B1 (en) * 1992-05-18 2002-05-28 Non-Invasive Technology, Inc. Non-invasive imaging of biological tissue
US5408093A (en) * 1992-08-31 1995-04-18 Hitachi, Ltd. Optical computed tomography equipment having image inverting optical device
US5420607A (en) * 1992-09-02 1995-05-30 Miller; Robert F. Electronic paintbrush and color palette
IL107396A (en) * 1992-11-09 1997-02-18 Boehringer Mannheim Gmbh Method and apparatus for analytical determination of glucose in a biological matrix
US5402778A (en) * 1993-01-19 1995-04-04 Nim Incorporated Spectrophotometric examination of tissue of small dimension
US5358503A (en) * 1994-01-25 1994-10-25 Bertwell Dale E Photo-thermal therapeutic device and method
DE4410888A1 (en) * 1994-03-29 1995-10-05 Zeiss Carl Jena Gmbh Apparatus for irradiating human tissue using multi-wavelength IR light
US5625458A (en) * 1994-11-10 1997-04-29 Research Foundation Of City College Of New York Method and system for imaging objects in turbid media using diffusive fermat photons
US5706821A (en) * 1994-12-30 1998-01-13 Hamamatsu Photonics K.K. Spectroscopic method for quantitatively determining the change of concentration of a light or other radiation absorbing compound in a medium which is interrogated through an intervening medium
US5655530A (en) * 1995-08-09 1997-08-12 Rio Grande Medical Technologies, Inc. Method for non-invasive blood analyte measurement with improved optical interface

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5007428A (en) * 1987-04-21 1991-04-16 The University Court Of The University Of Aberdeen Apparatus for examining a body of living tissues
US5596987A (en) * 1988-11-02 1997-01-28 Noninvasive Technology, Inc. Optical coupler for in vivo examination of biological tissue
US5555885A (en) * 1988-12-21 1996-09-17 Non-Invasive Technology, Inc. Examination of breast tissue using time-resolved spectroscopy
US5119815A (en) * 1988-12-21 1992-06-09 Nim, Incorporated Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation
US5899865A (en) * 1988-12-21 1999-05-04 Non-Invasive Technology, Inc. Localization of abnormal breast tissue using time-resolved spectroscopy
US4972331A (en) * 1989-02-06 1990-11-20 Nim, Inc. Phase modulated spectrophotometry
US4945239A (en) * 1989-03-29 1990-07-31 Center For Innovative Technology Early detection of breast cancer using transillumination
US5398685A (en) * 1992-01-10 1995-03-21 Wilk; Peter J. Endoscopic diagnostic system and associated method
US5386827A (en) * 1993-03-30 1995-02-07 Nim Incorporated Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7736382B2 (en) 2005-09-09 2010-06-15 Lockheed Martin Corporation Apparatus for optical stimulation of nerves and other animal tissue
US8985119B1 (en) 2005-09-09 2015-03-24 Lockheed Martin Corporation Method and apparatus for optical stimulation of nerves and other animal tissue
US8945197B1 (en) 2005-10-24 2015-02-03 Lockheed Martin Corporation Sight-restoring visual prosthetic and method using infrared nerve-stimulation light
US8956396B1 (en) 2005-10-24 2015-02-17 Lockheed Martin Corporation Eye-tracking visual prosthetic and method
US8506613B2 (en) 2006-09-21 2013-08-13 Lockheed Martin Corporation Miniature method and apparatus for optical stimulation of nerves and other animal tissue
US20080077198A1 (en) * 2006-09-21 2008-03-27 Aculight Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US7988688B2 (en) 2006-09-21 2011-08-02 Lockheed Martin Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US20110238141A1 (en) * 2006-09-21 2011-09-29 Lockheed Martin Corporation Miniature method and apparatus for optical stimulation of nerves and other animal tissue
US8996131B1 (en) 2006-09-28 2015-03-31 Lockheed Martin Corporation Apparatus and method for managing chronic pain with infrared light sources and heat
US9061135B1 (en) 2006-09-28 2015-06-23 Lockheed Martin Corporation Apparatus and method for managing chronic pain with infrared and low-level light sources
US8012189B1 (en) 2007-01-11 2011-09-06 Lockheed Martin Corporation Method and vestibular implant using optical stimulation of nerves
US8317848B1 (en) 2007-01-11 2012-11-27 Lockheed Martin Corporation Vestibular implant and method for optical stimulation of nerves
US8551150B1 (en) 2007-01-11 2013-10-08 Lockheed Martin Corporation Method and system for optical stimulation of nerves
US8632577B1 (en) 2007-01-19 2014-01-21 Lockheed Martin Corporation Hybrid optical-electrical probes for stimulation of nerve or other animal tissue
US7883536B1 (en) 2007-01-19 2011-02-08 Lockheed Martin Corporation Hybrid optical-electrical probes
US8357187B1 (en) 2007-01-19 2013-01-22 Lockheed Martin Corporation Hybrid optical-electrical probes for stimulation of nerve or other animal tissue
US8475506B1 (en) 2007-08-13 2013-07-02 Lockheed Martin Corporation VCSEL array stimulator apparatus and method for light stimulation of bodily tissues
US8998914B2 (en) 2007-11-30 2015-04-07 Lockheed Martin Corporation Optimized stimulation rate of an optically stimulating cochlear implant
US9011509B2 (en) 2007-11-30 2015-04-21 Lockheed Martin Corporation Individually optimized performance of optically stimulating cochlear implants
US9011508B2 (en) 2007-11-30 2015-04-21 Lockheed Martin Corporation Broad wavelength profile to homogenize the absorption profile in optical stimulation of nerves
US9277880B2 (en) 2008-07-03 2016-03-08 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US9591975B2 (en) 2008-07-03 2017-03-14 Masimo Corporation Contoured protrusion for improving spectroscopic measurement of blood constituents
US9717425B2 (en) 2008-07-03 2017-08-01 Masimo Corporation Noise shielding for a noninvaise device
US10376190B1 (en) 2008-07-03 2019-08-13 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US10299708B1 (en) 2008-07-03 2019-05-28 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US10258266B1 (en) 2008-07-03 2019-04-16 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US10376191B1 (en) 2008-07-03 2019-08-13 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US10292628B1 (en) 2008-07-03 2019-05-21 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US20110004082A1 (en) * 2008-07-03 2011-01-06 Jeroen Poeze Multi-stream data collection system for noninvasive measurement of blood constituents
US20100004518A1 (en) * 2008-07-03 2010-01-07 Masimo Laboratories, Inc. Heat sink for noninvasive medical sensor
US10335068B2 (en) 2008-07-03 2019-07-02 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US10258265B1 (en) 2008-07-03 2019-04-16 Masimo Corporation Multi-stream data collection system for noninvasive measurement of blood constituents
US8630691B2 (en) * 2008-08-04 2014-01-14 Cercacor Laboratories, Inc. Multi-stream sensor front ends for noninvasive measurement of blood constituents
US8909310B2 (en) * 2008-08-04 2014-12-09 Cercacor Laboratories, Inc. Multi-stream sensor front ends for noninvasive measurement of blood constituents
US20100030039A1 (en) * 2008-08-04 2010-02-04 Masimo Laboratories, Inc. Multi-stream sensor front ends for noninvasive measurement of blood constituents
US20100030040A1 (en) * 2008-08-04 2010-02-04 Masimo Laboratories, Inc. Multi-stream data collection system for noninvasive measurement of blood constituents
US8498699B2 (en) 2008-10-03 2013-07-30 Lockheed Martin Company Method and nerve stimulator using simultaneous electrical and optical signals
US9668680B2 (en) 2009-09-03 2017-06-06 Masimo Corporation Emitter driver for noninvasive patient monitor
US9186102B2 (en) 2009-09-03 2015-11-17 Cercacor Laboratories, Inc. Emitter driver for noninvasive patient monitor
US20130123643A1 (en) * 2010-04-12 2013-05-16 Holger Jungmann Measuring arrangement for recording a spectrum, in particular from vital tissue
US8792978B2 (en) 2010-05-28 2014-07-29 Lockheed Martin Corporation Laser-based nerve stimulators for, E.G., hearing restoration in cochlear prostheses and method
US8864806B2 (en) 2010-05-28 2014-10-21 Lockheed Martin Corporation Optical bundle apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves
US8652187B2 (en) 2010-05-28 2014-02-18 Lockheed Martin Corporation Cuff apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves
US8968376B2 (en) 2010-05-28 2015-03-03 Lockheed Martin Corporation Nerve-penetrating apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves
US20130248695A1 (en) * 2010-10-29 2013-09-26 Duncan MacIntyre Method and apparatus for analyte detection
US8747447B2 (en) 2011-07-22 2014-06-10 Lockheed Martin Corporation Cochlear implant and method enabling enhanced music perception
US8834545B2 (en) 2011-07-22 2014-09-16 Lockheed Martin Corporation Optical-stimulation cochlear implant with electrode(s) at the apical end for electrical stimulation of apical spiral ganglion cells of the cochlea
US8894697B2 (en) 2011-07-22 2014-11-25 Lockheed Martin Corporation Optical pulse-width modulation used in an optical-stimulation cochlear implant
US8840654B2 (en) 2011-07-22 2014-09-23 Lockheed Martin Corporation Cochlear implant using optical stimulation with encoded information designed to limit heating effects
US8709078B1 (en) 2011-08-03 2014-04-29 Lockheed Martin Corporation Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light

Also Published As

Publication number Publication date
WO1996020638A1 (en) 1996-07-11
US20040054290A1 (en) 2004-03-18
US6526309B1 (en) 2003-02-25
EP0808124A1 (en) 1997-11-26
CA2209240C (en) 2009-07-21
JP3725156B2 (en) 2005-12-07
DE69627477T2 (en) 2004-03-18
EP0906052A1 (en) 1999-04-07
EP0808124B1 (en) 2003-04-16
EP0906052A4 (en) 1999-04-07
CN1230118C (en) 2005-12-07
EP0906052B1 (en) 2006-05-10
CA2209240A1 (en) 1996-07-11
US20060241502A1 (en) 2006-10-26
CN1169665A (en) 1998-01-07
WO1997020494A1 (en) 1997-06-12
JPH10511875A (en) 1998-11-17
EP0808124A4 (en) 1998-08-19
US5987351A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
Wilson et al. Optical reflectance and transmittance of tissues: principles and applications
Pogue et al. Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast
US6630673B2 (en) Non-invasive sensor capable of determining optical parameters in a sample having multiple layers
US7231243B2 (en) Optical methods for tissue analysis
US6282438B1 (en) Optical system for measuring metabolism in a body and imaging method
US7301629B2 (en) Apparatus and method for determining tissue characteristics
US6577391B1 (en) Apparatus and method for determining tissue characteristics
US8078250B2 (en) Method for spectrophotometric blood oxygenation monitoring
JP3594534B2 (en) Apparatus for detecting a substance
US7047055B2 (en) Fetal pulse oximetry
US8116845B2 (en) Tissue-characterization probe with effective sensor-to-tissue contact
Cysewska-Sobusiak Metrological problems with noninvasive transillumination of living tissues
JP4474050B2 (en) Multi-mode optical tissue diagnosis system
US7747301B2 (en) Apparatus and method for non-invasive and minimally-invasive sensing of parameters relating to blood
JP3619969B2 (en) Light sensor having a plurality light sources
US8538507B2 (en) Infrared endoscopic balloon probes
US6706004B2 (en) Balloon catheter
CA2731409C (en) Quantitative multi-spectral opto-acoustic tomography (msot) of tissue biomarkers
US5137023A (en) Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography
EP1601285B1 (en) Blood optode
JP3625475B2 (en) Noninvasively system for monitoring the hematocrit
US6741884B1 (en) Infrared endoscopic balloon probes
ES2312220T3 (en) Device for the non-invasive determination of the conversion of oxygen in fabrics.
US6498942B1 (en) Optoacoustic monitoring of blood oxygenation
JP2015232574A (en) Method and device for multispectral photonic imaging

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION